1.Effects of 2-methoxyestradiol on the expressions of hypoxia-inducible factor 1α and apoptosis related genes in rat hippocampus following global cerebral ischemia
Jing-Hua PENG ; Hong-Ri ZHANG ; Li-Na HUANG ; Xiao-Bing CHENC ; Tao CUI ; Yun LI
Chinese Journal of Neuromedicine 2009;8(9):884-888
Objective To investigate the effect of 2-methoxyestradiol(2ME2)on the expressions of hypoxia-inducible factor 1α and apoptosis-related genes(RTP801 and caspase-3)in the hippocampus of rats following global cerebral ischemia.Methods A total of 168 adult male SD rats were randomized into 2 groups,global cerebral isehemia group(GI group,n=84)and global cerebral ischemia+2ME2 treatment group(GI+2ME2 group,n=84).In GI and GI+2ME2 groups,4 vessel occlusion(4-vo)global ischemia was induced,and the rats were sacrificed at 6,12,24,48,96h,and 5 and 7 days after the reperfusion.Nissl staining was used for quantitative analysis of the hippocampal neurons,and immunohistochemistry and RT-PCR were performed to detect the expressions of HIF-1α protein,caspase-3 protein and RTP801 mRNA.Results At 48,96h and 5 and 7 days after the reperfusion,the numbers of hippocampal neurons in GI+2ME2 group were 37.09±3.52,26.93±3.10,22.22±3.091,and 6.98±3.07,respectively,significantly higher than those in GI group(P<0.05).2ME2 significantly suppressed the expression levels of HIF-1α and reduced the numbers of the cells positive for HIF-1α protein to 1 1.47±1.9,20.27±2.07,3.12±0.89,1.07±0.83 at these time points(P<0.05).The expressions of caspase-3 protein were decreased significantly in GI+2ME2 group,with the numbers of positive cells of 12.39±1.67,20.65±2.01,15.61±1.26,and 6.57±1.12 at the time points.The absorbance of RTP801 mRNA expression at the time points from 12 h to 5 days in GI+2ME2 group was 0.750±0.078,1.008±0.090,0.717±0.072,0.43 1±0.047,and 0.23 1±0.028,respectively,significantly lower than that in GI group(P<0.05).Conclusion 2ME2 offers brain protection in rats with global cerebral ischemia and suppresses the elevation in the expressions of hypoxia-inducible factor 1α,RTP801 and caspase-3.
2.The Characteristics of Capgras Syndrome in Patients Diagnosed as Probable Alzheimer Disease.
Il Mi JANG ; Hakjae ROH ; Moo Young AHN ; Young Soon YANG ; Hae Ri NA ; Sang Yun KIM
Soonchunhyang Medical Science 2011;17(2):72-74
OBJECTIVE: We assessed the characteristics of Capgras syndrome in patients diagnosed as probable Alzheimer disease, and compared the clinical and imaging findings with other previous reports. METHODS: We obtained medical records of patients with Capgras syndrome diagnosed as probable Alzheimer disease in three hospitals from March 2009 to March 2010. The basic characteristics, neuropsychologic tests, brain imaging data were investigated. RESULTS: The mean age of the patients was 74.7 years old and all of the patients experienced this syndrome in relation to a spouse. Brain magnetic resonance imaging showed mild-to-moderate global atrophy, variable hippocampal atrophy in this study. The Mini-Mental State Examination mean scores were 18.78 and clinical dementia rating scores were from 1 to 2. All of the patients took medicine of acetycholine esterase inhibitors and two patients recovered with antipsychotic medication. Five patients had showed continuous Capgras syndrome, at the last follow-up day, for a year. CONCLUSION: Capgras syndrome patients in this study who were diagnosed as probable Alzheimer disease showed similar results to the individuals from other reports. More study is needed to estimate the numbers and characteristics of patients with this syndrome.
Alzheimer Disease
;
Atrophy
;
Brain
;
Capgras Syndrome
;
Dementia
;
Follow-Up Studies
;
Humans
;
Magnetic Resonance Imaging
;
Medical Records
;
Neuroimaging
;
Neuropsychological Tests
;
Spouses
3.A case of recurred malignant melanoma of the stomach and peritoneum.
Sang Woo NAM ; Na Ri LEE ; Tae Hwan LEE ; Eun Kee SONG ; Jae Yong KWAK ; Chang Yeol YIM ; Kyu Yun JANG
Korean Journal of Medicine 2007;72(2):213-216
Malignant melanoma may spread through the lymphatic channels or via the bloodstream. The lung, liver, bone and brain are common sites of hematogenous metastases. Malignant melanoma that has recurred to the stomach or peritoneum is not common. An 83-year old male patient was admitted to the Department of Oncology due to abdominal distension; 13 years ago, the patient had previously received a complete surgical resection for malignant melanoma of the right heel. According to a computed tomography (CT) scan of the abdomen, peritoneal carcinomatosis was suggested. Under a gastrofiberoscopic examination, two small sized polyps with central umbilication were found on the midbody of the stomach. The gastric polyps were histopathologically confirmed as metastatic melanoma. We report a rare case of metastatic malignant melanoma that has recurred to the stomach and peritoneum 13years after its initial diagnosis.
Abdomen
;
Aged, 80 and over
;
Brain
;
Carcinoma
;
Diagnosis
;
Heel
;
Humans
;
Liver
;
Lung
;
Male
;
Melanoma*
;
Neoplasm Metastasis
;
Peritoneum*
;
Polyps
;
Stomach*
4.Detection of Botulinum Neurotoxin Type A by In Vitro Bioassay Based on Endopeptidase Activity.
Yun Jeong KIM ; Joung Hee BAEK ; Jeong Hee KIM ; Bong Su KIM ; Gi eun RHIE ; Cheon Kwon YOO ; Na Ri SHIN
Journal of Bacteriology and Virology 2010;40(1):29-37
Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that cleaves SNAP-25 (synaptosome-associated protein of 25 kDa), a specific cellular protein essential for neurotransmitter release. As well as mouse bioassay to detect BoNT/A, various assay methods based on its endopeptidase activity have been developed. In this study, we tried to develop a BoNT/A assay system using recombinant SNAP-25 with glutathione S-transferase (GST) tags at both termini as substrate. The recombinant GST-SNAP-25-GST with 70 kDa was expressed and purified in E. coli and synthesized N-terminal 50 kDa and C-terminal 25 kDa fragment after cleavage at the Gln(197)-Arg(198) bond by BoNT/A. To detect both fragments, we obtained rabbit antisera against peptides corresponding to the cleaved ends of each fragment. In the western blotting, the N-terminal fragment was detected by the antibody specifically recognizing the newly exposed C-terminus (corresponding to amino acid residue 191-197). This assay system was able to detect until 3.125 ng of BoNT/A, which corresponded to about 90 fold LD50 in mice. These results suggest that the in vitro endopeptidase assay developed in this study would replace others to detect BoNT/A.
Animals
;
Biological Assay
;
Blotting, Western
;
Glutathione Transferase
;
Immune Sera
;
Lethal Dose 50
;
Mice
;
Neurotransmitter Agents
;
Peptides
5.Detection of Botulinum Neurotoxin Type A by In Vitro Bioassay Based on Endopeptidase Activity.
Yun Jeong KIM ; Joung Hee BAEK ; Jeong Hee KIM ; Bong Su KIM ; Gi eun RHIE ; Cheon Kwon YOO ; Na Ri SHIN
Journal of Bacteriology and Virology 2010;40(1):29-37
Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that cleaves SNAP-25 (synaptosome-associated protein of 25 kDa), a specific cellular protein essential for neurotransmitter release. As well as mouse bioassay to detect BoNT/A, various assay methods based on its endopeptidase activity have been developed. In this study, we tried to develop a BoNT/A assay system using recombinant SNAP-25 with glutathione S-transferase (GST) tags at both termini as substrate. The recombinant GST-SNAP-25-GST with 70 kDa was expressed and purified in E. coli and synthesized N-terminal 50 kDa and C-terminal 25 kDa fragment after cleavage at the Gln(197)-Arg(198) bond by BoNT/A. To detect both fragments, we obtained rabbit antisera against peptides corresponding to the cleaved ends of each fragment. In the western blotting, the N-terminal fragment was detected by the antibody specifically recognizing the newly exposed C-terminus (corresponding to amino acid residue 191-197). This assay system was able to detect until 3.125 ng of BoNT/A, which corresponded to about 90 fold LD50 in mice. These results suggest that the in vitro endopeptidase assay developed in this study would replace others to detect BoNT/A.
Animals
;
Biological Assay
;
Blotting, Western
;
Glutathione Transferase
;
Immune Sera
;
Lethal Dose 50
;
Mice
;
Neurotransmitter Agents
;
Peptides
6.Analysis of Reasons for Continuing Education in Dietitians.
Cheong Min SOHN ; Young Yun CHO ; Mi Yong BEA ; Eun Kyoung DO ; Woo Ri NA ; Mi Sung KIM
Journal of the Korean Dietetic Association 2013;19(4):416-423
This study analyzed the reasons for continuing education among dietitians. An internet-based survey of 622 dieticians was conducted from August 31, 2012 to September 12, 2012. Based on data from the Participation Reasons Scale (PRS) questionnaire, factor analysis was conducted by principle component analysis for the extraction of major factors. Subsequent reliability analysis was performed by assessing Cronbach's alpha. The ANOVA-test was performed to compare the participation reason scores for each factors according to general characteristics. Statistical analysis was performed using SPSS ver.17.0, and P<0.05 was considered significant. Factor analysis for the participation reasons revealed four types of factors. These factors were "maintenance and development of professional competencies", "interaction and responsibility of professionals", "job stability and personal profits" and "services for customers" respectively. Among the participation reasons, "maintenance and development of professional competencies" was the first reason with a 29.34% variance. In addition, the participation reasons for continuing education differed according to age (P<0.05), the highest level of education (P<0.05), workplace (P<0.01), and work experience in dietetic area (P<0.001). In conclusion, continuing education programs for dietitians should focus on effectively developing and promoting professionalism.
Education
;
Education, Continuing*
;
Humans
;
Surveys and Questionnaires
7.A Case of Advanced Gastric Cancer Concomitant with Pyogenic Liver Abscess in the Patient with Subtotal Gastrectomy.
Dong Hee PARK ; Nae Yun HEO ; Heon SA-KONG ; Na Ri JEONG ; Su Jin JEONG ; Sung Jin OH ; Kyung Han NAM
The Korean Journal of Gastroenterology 2017;69(2):143-146
The hematogenous spreading of an infectious pathogen via the portal vein from a mucosal injury in the gastrointestinal tract has been considered as one of the pathologic mechanisms of pyogenic liver abscess. Several studies have presented the association between colorectal cancer and pyogenic liver abscess. However, the cases of stomach cancer concomitant with pyogenic liver abscess have rarely been reported in the world. Herein, we present a case of advanced gastric cancer concomitant with pyogenic liver abscess in a patient who previously underwent subtotal gastrectomy due to peptic ulcer perforation.
Colorectal Neoplasms
;
Gastrectomy*
;
Gastrointestinal Tract
;
Humans
;
Liver Abscess, Pyogenic*
;
Peptic Ulcer Perforation
;
Portal Vein
;
Stomach Neoplasms*
8.A case of multiple symmetric lipomatosis with acute renal failure due to pulmonary thromboembolism.
Na Ri LEE ; Heung Yong JIN ; Seoung Ju PARK ; Il Yong YUN ; Hyeok Jin KWON ; Chi Young MOON ; Won KIM ; Sung Kwang PARK ; Sung Kyew KANG
Korean Journal of Medicine 2002;62(5):575-580
Multiple symmetric lipomatosis (MSL) is a rare disease characterized by the presence of diffuse, non-tender, symmetric deposits of adipose tissue on the neck, back and upper part of the trunk. It has been reported that this disease could be associated with various metabolic abnormalities such as impaired glucose tolerance, hyperuricemia, alcohol consumption, type 4 hyperlipidemia, renal tubular acidosis and thyroid disorder. We present a case of type 2 MSL with pulmonary thromboembolism. He suffered sudden dyspnea and decreased urine output. The causes of dyspnea and acute renal failure (ARF) in this case were dehydration and hemodynamic disturbance due to pulmonary thromboembolism. After thrombolytic and fluid therapy, his condition was improved. He was discharged on warfarin medication and has remained asymptomatic for 12 months.
Acidosis, Renal Tubular
;
Acute Kidney Injury*
;
Adipose Tissue
;
Alcohol Drinking
;
Dehydration
;
Dyspnea
;
Fluid Therapy
;
Glucose
;
Hemodynamics
;
Hyperlipidemias
;
Hyperuricemia
;
Lipomatosis, Multiple Symmetrical*
;
Neck
;
Pulmonary Embolism*
;
Rare Diseases
;
Thyroid Gland
;
Warfarin
9.Development of Capture ELISA Using a Biotinylated Monoclonal Antibody for Detection of Botulinum Neurotoxin Type A.
Yun Jeong KIM ; Na Ri SHIN ; Jeong Hee KIM ; So Yeon YOON ; Gi Eun RHIE ; Bong Su KIM ; Hee Bok OH
Journal of Bacteriology and Virology 2008;38(3):119-125
A capture enzyme-linked immunosorbent assay (capture ELISA) was developed to detect Clostridium botulinum neurotoxin type A (BoNT/A) in assay buffer and human serum. The assay is based upon affinity-purified rabbit polyclonal and biotinylated monoclonal antibodies directed against the BoNT/A complex purified from C. botulinum ATCC19397. For the capture ELISA, the optimized amount (2 microgram/ml) of rabbit polyclonal antibody was immobilized on ELISA plates to detect BoNT/A (ranging from 0 to 500 ng/ml), which was recognized by 2 microgram/ml of the monoclonal antibody. From three independent repeated experiments, standard curves were linear over the range of 0~31.25 ng/ml BoNT/A and the coefficients (r(2)) ranged from 0.9951~0.9999 for all assays. The inter-variations were typically 0.50~6.93% and the specificity was confirmed by showing no cross-reactivity against BoNT/B and /E. The detection limit of capture ELISA was 0.488 ng/ml, which was close to mouse LD(50). In addition, application with BoNT/A-spiking human sera showed a possibility to detect BoNT/A with capture ELISA from the contaminated human sera. Taken together, the newly developed capture ELISA could serve as a rapid and sensitive screening tool for detecting BoNT/A simultaneously from massive specimens.
Animals
;
Antibodies, Monoclonal
;
Clostridium botulinum
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Limit of Detection
;
Mass Screening
;
Mice
;
Sensitivity and Specificity
10.Activities of Daily Living and Dementia.
Youngsoon YANG ; Hyun Duk YANG ; Yun Jung HONG ; Jung Eun KIM ; Moon Ho PARK ; Hae Ri NA ; Il Woo HAN ; Sangyun KIM
Dementia and Neurocognitive Disorders 2012;11(2):29-37
Activities of daily living (ADL) refer to the ability to care for self and perform daily activities within an individual's place or in outdoor environments. ADL comprise two main categories: Basic or physical ADL and Instrumental ADL. The latter allows for the earlier detection of functional decline than the former. The cognitive changes in neurodegenerative dementias contribute to the impaired ability of the patients to take care of themselves. Activities of daily living is a major criterion for diagnosing dementia. Furthermore, it has recently been emphasized that some impairment of activities of daily living, particularly of complex instrumental functions, is already present even in mild cognitive impairment prodromal stage of dementia, although mild cognitive impairment is distinguished from dementia by the absence of significant deficit in activities of daily living. The impaired activities of daily living increase the rate of institutionalization of the patients with dementia to nursing home and inevitably bring about the changes in the qualities of life not only of the patients but their caregivers. One of the best ways to evaluate the degree of impairment in activities of daily living and the care burden is through standardized functional assessment tools according to the severity of dementia. These tools provide objective data, thereby allowing the clinicians to judge decline and improvement in the functional status and to plan individualized care. In this review, we will review the clinical significance of evaluating ADL, the assessment tools according to the severity of dementia, and therapeutic approaches to enhance the functional levels. We will also review the impact of the impaired ADL on the quality of life among the patients and their care providers.
Activities of Daily Living
;
Caregivers
;
Dementia
;
Humans
;
Hypogonadism
;
Institutionalization
;
Mild Cognitive Impairment
;
Mitochondrial Diseases
;
Nursing Homes
;
Ophthalmoplegia
;
Prodromal Symptoms
;
Quality of Life